Literature DB >> 9445005

The major site of phosphorylation within the Rous sarcoma virus MA protein is not required for replication.

T D Nelle1, M F Verderame, J Leis, J W Wills.   

Abstract

About one-third of the MA protein in Rous sarcoma virus (RSV) is phosphorylated. Previous analyses of this fraction have suggested that serine residues 68 and 106 are the major sites of phosphorylation. As a follow-up to that study, we have characterized mutants which have these putative phosphorylation sites changed to alanine, either separately or together. None of the substitutions (S68A, S106A, or S68/106A) had an effect on the budding efficiency or infectivity of the virus. Upon examination of the 32P-labeled viral proteins, we found that the S68A substitution did not affect phosphorylation in vivo at all. In contrast, the S106A substitution prevented all detectable phosphorylation of MA, suggesting that there is only one major site of phosphorylation in MA. We also found that the RSV MA protein is phosphorylated on tyrosine, but the amount was low and detectable only with large numbers of virions and an antibody specific for phosphotyrosine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445005      PMCID: PMC124583     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.

Authors:  R C Craven; R P Bennett; J W Wills
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  Form, function, and use of retroviral gag proteins.

Authors:  J W Wills; R C Craven
Journal:  AIDS       Date:  1991-06       Impact factor: 4.177

3.  HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase.

Authors:  P Gallay; S Swingler; J Song; F Bushman; D Trono
Journal:  Cell       Date:  1995-11-17       Impact factor: 41.582

Review 4.  Serine/threonine protein phosphatases in the control of cell function.

Authors:  A A Depaoli-Roach; I K Park; V Cerovsky; C Csortos; S D Durbin; M J Kuntz; A Sitikov; P M Tang; A Verin; S Zolnierowicz
Journal:  Adv Enzyme Regul       Date:  1994

5.  Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein.

Authors:  R C Craven; A E Leure-duPree; C R Erdie; C B Wilson; J W Wills
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

6.  HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator.

Authors:  P Gallay; S Swingler; C Aiken; D Trono
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

7.  Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein.

Authors:  R C Craven; A E Leure-duPree; R A Weldon; J W Wills
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein.

Authors:  L J Parent; C B Wilson; M D Resh; J W Wills
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.

Authors:  R P Bennett; T D Nelle; J W Wills
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Authors:  M I Bukrinsky; S Haggerty; M P Dempsey; N Sharova; A Adzhubel; L Spitz; P Lewis; D Goldfarb; M Emerman; M Stevenson
Journal:  Nature       Date:  1993-10-14       Impact factor: 69.504

View more
  5 in total

1.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  trans-acting inhibition of genomic RNA dimerization by Rous sarcoma virus matrix mutants.

Authors:  R A Garbitt; J A Albert; M D Kessler; L J Parent
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Repositioning basic residues in the M domain of the Rous sarcoma virus gag protein.

Authors:  E M Callahan; J W Wills
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles.

Authors:  Barbara Müller; Tilo Patschinsky; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 5.  Post-Translational Modifications of Retroviral HIV-1 Gag Precursors: An Overview of Their Biological Role.

Authors:  Charlotte Bussienne; Roland Marquet; Jean-Christophe Paillart; Serena Bernacchi
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.